Physician

Long Huynh-Duc, D.O.

According to 2025 Medicare claims, Long Huynh-Duc, D.O. (NPI: 1447572169) practices rheumatology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is PIEDMONT ARTHRITIS CLINIC PA (NPI: 1124199773; TIN: 570702625) and primary practice location at 29601-3973. Huynh-Duc is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Huynh-Duc's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,010 traditional Medicare patients, billed 347,170 HCPCS/CPT codes, and received $3,310,164 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 4,724 prescription claims across 728 beneficiaries totaling $4,763,896 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 190 records totaling $7,927. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $312,850 to $3,310,164. Similarly, Part D prescription costs have risen steadily, from $2,233,747 to $4,763,896. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	205	11,762	$312,850
2016	393	36,440	$715,267
2017	463	48,988	$1,008,863
2018	463	68,116	$1,421,069
2019	597	119,149	$2,683,984
2020	622	188,899	$3,614,289
2021	651	240,766	$3,928,061
2022	855	240,579	$3,289,892
2023	1,072	310,172	$3,404,448
2024	1,010	347,170	$3,310,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	449	3,048	$2,233,747
2016	559	2,701	$1,250,875
2017	488	2,587	$2,864,315
2018	499	2,640	$4,593,491
2019	583	3,221	$3,312,102
2020	644	3,983	$2,767,400
2021	587	4,032	$3,089,484
2022	585	3,896	$2,877,866
2023	812	5,173	$4,800,989
2024	728	4,724	$4,763,896

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$649
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	421	850	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	470	731	$84
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	305	1,069	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	256	290	$12
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	492	938	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	102	3,304	$1,136,189
Cortrophin	Corticotropin	14	428	$944,584
Enbrel Sureclick	Etanercept	72	2,380	$639,742
Orencia Clickject	Abatacept	68	2,072	$438,411
Rinvoq	Upadacitinib	50	1,500	$342,092

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	189	$6,310	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,618	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Long Huynh-Duc, D.O.?

Tedicare shows public-source Medicare data for Long Huynh-Duc, D.O. (NPI 1447572169), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Long Huynh-Duc, D.O. have ACO affiliation data?

Long Huynh-Duc, D.O. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Long Huynh-Duc, D.O.?

Long Huynh-Duc, D.O. is linked to PIEDMONT ARTHRITIS CLINIC PA (billing NPI 1124199773) in the available physician profile data.

Does Long Huynh-Duc, D.O. have Open Payments data?

Long Huynh-Duc, D.O. has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.